The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. (vol 18, pg 254, 2001)

Soler, M Matz, J Townley, R Buhl, R O'Brien, J Fox, H Thirlwell, J Gupta, N Della Cioppa, G

M. Soler et al., The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. (vol 18, pg 254, 2001), EUR RESP J, 18(4), 2001, pp. 739-740

1

Cardiovascular & Respiratory Systems","da verificare

EUROPEAN RESPIRATORY JOURNAL

09031936 → ACNP

18

4

2001

739 - 740

ISI

0903-1936(200110)18:4<739:TAAORE>2.0.ZU;2-5